AxoGen Inc
NASDAQ:AXGN
AxoGen Inc
Accounts Receivables
AxoGen Inc
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AxoGen Inc
NASDAQ:AXGN
|
Accounts Receivables
$24.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
28%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accounts Receivables
$2.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Receivables
$2.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Accounts Receivables
$3.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Receivables
$6.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Receivables
$1.1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
17%
|
See Also
What is AxoGen Inc's Accounts Receivables?
Accounts Receivables
24.2m
USD
Based on the financial report for Mar 31, 2024, AxoGen Inc's Accounts Receivables amounts to 24.2m USD.
What is AxoGen Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
28%
Over the last year, the Accounts Receivables growth was 9%. The average annual Accounts Receivables growth rates for AxoGen Inc have been 7% over the past three years , 10% over the past five years , and 28% over the past ten years .